|Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial|
IS Allsop, David J., Copeland, Jan, Lintzeris, Nicholas, Dunlop, Adrian J ...
JAMA Psychiatry 71 (3), 281-291, 2014
|Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study|
M Alavi, J Grebely, M Micallef, AJ Dunlop, AC Balcomb, CA Day, ...
Clinical Infectious Diseases 57 (suppl_2), S62-S69, 2013
|LAAM maintenance vs methadone maintenance for heroin dependence|
NC Clark, N Lintzeris, A Gijsbers, G Whelan, A Dunlop, A Ritter, WW Ling
Cochrane Database of Systematic Reviews, 2002
|Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial|
J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ...
The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018
|A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine–naloxone for heroin dependence|
J Bell, M Shanahan, C Mutch, F Rea, A Ryan, R Batey, A Dunlop, ...
Addiction 102 (12), 1899-1907, 2007
|Concurrent buprenorphine and benzodiazepines use and self‐reported opioid toxicity in opioid substitution treatment|
S Nielsen, P Dietze, N Lee, A Dunlop, D Taylor
Addiction 102 (4), 616-622, 2007
|National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence|
N Lintzeris, N Clark, P Muhleisen, A Ritter, R Ali, J Bell, L Gowing, ...
|Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study|
J Grebely, M Alavi, M Micallef, AJ Dunlop, AC Balcomb, N Phung, ...
Addiction 111 (2), 311-319, 2016
|Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study|
AD Marshall, M Micallef, A Erratt, J Telenta, C Treloar, H Everingham, ...
International Journal of Drug Policy 26 (10), 984-991, 2015
|National guidelines for medication-assisted treatment of opioid dependence|
L Gowing, R Ali, A Dunlop, M Farrell, N Lintzeris
Canberra: Commonwealth of Australia, 38-9, 2014
|A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence|
N Lintzeris, SY Leung, AJ Dunlop, B Larance, N White, GR Rivas, ...
Drug and alcohol dependence 131 (1-2), 119-126, 2013
|Validation and implementation of the A ustralian Treatment Outcomes Profile in specialist drug and alcohol settings|
A Ryan, J Holmes, V Hunt, A Dunlop, K Mammen, R Holland, Y Sutton, ...
Drug and Alcohol Review 33 (1), 33-42, 2014
|Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia|
J Keats, M Micallef, J Grebely, S Hazelwood, H Everingham, N Shrestha, ...
International Journal of Drug Policy 26 (10), 999-1006, 2015
|Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis|
S Fraser, K Pienaar, E Dilkes-Frayne, D Moore, R Kokanovic, C Treloar, ...
International Journal of Drug Policy 44, 192-201, 2017
|An iterative model for in vitro laboratory assessment of tamper deterrent formulations|
EJ Cone, J Giordano, B Weingarten
Drug and alcohol dependence 131 (1-2), 100-105, 2013
|Changes in cigarette and alcohol use during cannabis abstinence|
DJ Allsop, AJ Dunlop, C Sadler, GR Rivas, IS McGregor, J Copeland
Drug and alcohol dependence 138, 54-60, 2014
|Boundary violations, gender and the nature of nursing work|
M Chiarella, A Adrian
Nursing Ethics 21 (3), 267-277, 2014
|Assessing pregnant women's compliance with different alcohol guidelines: an 11‐year prospective study|
JR Powers, DJ Loxton, LA Burns, A Shakeshaft, EJ Elliott, AJ Dunlop
Medical Journal of Australia 192 (12), 690-693, 2010
|Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified|
S Nielsen, S Nielsen, P Dietze, S Nielsen, P Dietze, A Dunlop, S Nielsen, ...
Drug and Alcohol Review 26 (2), 143-151, 2007
|Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal|
DJ Allsop, N Lintzeris, J Copeland, A Dunlop, IS McGregor
Clinical Pharmacology & Therapeutics 97 (6), 571-574, 2015